BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 1372058)

  • 1. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis.
    Marx A; Kirchner T; Greiner A; Müller-Hermelink HK; Schalke B; Osborn M
    Lancet; 1992 Mar; 339(8795):707-8. PubMed ID: 1372058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofilament expression in thymic epithelial tumors and anti-axonal autoantibodies in myasthenia gravis: a model for autoimmunity by abnormal T cell selection].
    Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1992; 76():256-61. PubMed ID: 1283271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis-associated thymic epithelial tumors express neurofilaments and are associated with antiaxonal autoimmunity.
    Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
    Ann N Y Acad Sci; 1993 Jun; 681():107-9. PubMed ID: 8357158
    [No Abstract]   [Full Text] [Related]  

  • 5. Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies.
    Nagvekar N; Jacobson LW; Willcox N; Vincent A
    Clin Exp Immunol; 1998 Apr; 112(1):17-20. PubMed ID: 9566784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament is an autoantigenic determinant in myasthenia gravis.
    Schultz A; Hoffacker V; Wilisch A; Nix W; Gold R; Schalke B; Tzartos S; Müller-Hermelink HK; Marx A
    Ann Neurol; 1999 Aug; 46(2):167-75. PubMed ID: 10443881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A striational muscle antigen and myasthenia gravis-associated thymomas share an acetylcholine-receptor epitope.
    Marx A; Osborn M; Tzartos S; Geuder KI; Schalke B; Nix W; Kirchner T; Müller-Hermelink HK
    Dev Immunol; 1992; 2(2):77-84. PubMed ID: 1379503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.
    Marx A; Wilisch A; Schultz A; Greiner A; Magi B; Pallini V; Schalke B; Toyka K; Nix W; Kirchner T; Müller-Hermelink HK
    Am J Pathol; 1996 Jun; 148(6):1839-50. PubMed ID: 8669470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
    Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
    J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extractable nuclear antigen autoantibodies and their association with other autoantibodies and thymoma in myasthenia gravis.
    Warlow R; Garlepp M; Dawkins R
    J Neuroimmunol; 1985 May; 8(2-3):185-97. PubMed ID: 3873473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.
    Aarli JA; Lefvert AK; Tönder O
    J Neuroimmunol; 1981 Dec; 1(4):421-7. PubMed ID: 7346525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine receptor epitope in proteins of myasthenia gravis-associated thymomas and non-thymic tissues.
    Marx A; O'Connor R; Tzartos S; Kalies I; Kirchner T; Müller-Hermelink HK
    Thymus; 1989; 14(1-3):171-8. PubMed ID: 2482999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma.
    Fujii Y; Monden Y; Nakahara K; Hashimoto J; Kawashima Y
    Neurology; 1984 Sep; 34(9):1182-6. PubMed ID: 6611521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
    Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
    Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.